Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study
ter Maat, L. S.; Van Duin, I. A. J.; Verheijden, R. J.; Moeskops, P.; Verhoeff, J. J. C.; Elias, S. G.; van Amsterdam, W. A. C.; Burgers, F. H.; Van den Berkmortel, F. W. P. J.; Boers-Sonderen, M. J.; Boomsma, M. F.; De Groot, J. W.; Haanen, J. B. A. G.; Hospers, G. A. P.; Piersma, D.; Vreugdenhil, G.; Westgeest, H. M.; Kapiteijn, E.; Labots, M.; Veldhuis, W. B. A. G.; Van Diest, P. J.; De Jong, P. A.; Pluim, J. P. W.; Leiner, T.; Veta, M.; Suijkerbuijk, K. P. M.
Show abstract
IntroductionThe association of body composition with checkpoint inhibitor outcomes in melanoma is a matter of ongoing debate. In this study, we aim to add to previous evidence by investigating body mass index (BMI) alongside CT derived body composition metrics in the largest cohort to date. MethodPatients treated with first-line anti-PD1 {+/-} anti-CTLA4 for advanced melanoma were retrospectively identified from 11 melanoma reference centers in The Netherlands. Age, sex, Eastern Cooperative Oncology Group performance status, serum lactate dehydrogenase, presence of brain and liver metastases, number of affected organs and BMI at baseline were extracted from electronic patient files. From baseline CT scans, five body composition metrics were automatically extracted: skeletal muscle index, skeletal muscle density, skeletal muscle gauge, subcutaneous adipose tissue index and visceral adipose tissue index. All predictors were correlated in uni- and multivariable analysis to progression-free, overall and melanoma-specific survival (PFS, OS and MSS) using Cox proportional hazards models. ResultsA total of 1471 eligible patients were included. Median PFS and OS were 8.8 and 34.8 months, respectively. A significantly worse PFS was observed in underweight patients (multivariable HR=1.87, 95% CI 1.14-3.07). Furthermore, better OS was observed in patients with higher skeletal muscle density (multivariable HR=0.91, 95% CI 0.83-0.99) and gauge (multivariable HR=0.88, 95% CI 0.84-0.996), and a worse OS with higher visceral adipose tissue index (multivariable HR=1.13, 95% CI 1.04-1.22). No association with survival outcomes was found for overweightness or obesity and survival outcomes, or for subcutaneous adipose tissue. DiscussionOur findings suggest that underweight BMI is associated with worse PFS, whereas higher skeletal muscle density and lower visceral adipose tissue index were associated with better OS. These associations were independent of previously identified predictors, including sex, age, performance status and extent of disease. No significant association between higher BMI and survival outcomes was observed.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors 94%
- Use of high-plex data reveals novel insights into the tumour microenvironment of clear cell renal cell carcinoma 93%
- Machine learning for prediction of immunotherapy efficacy in non-small cell lung cancer from simple clinical and biological data 92%
Similar papers in this journal
- The RNA-binding protein HuR impairs adipose tissue anabolism in pancreatic cancer cachexia 89%
- From Symptom to Outcome: Defining Clinically Meaningful Patient-Reported Appetite Loss in Non-Small-Cell Lung Cancer 89%
- Targeting interleukin-1 for reversing fat browning and muscle wasting in infantile nephropathic cystinosis 89%
Similar papers in this journal
- Study Protocol of A Phase II Study to Evaluate Safety and Efficacy of Neo-adjuvant Pembrolizumab and Radiotherapy in Localized Rectal Cancer 92%
- Landscape of Clinical Trials in Cancer Cachexia: Assessment of Trends From 1995-2024 92%
- Feasibility of Administering Human Pancreatic Cancer Chemotherapy in a Spontaneous Pancreatic Cancer Mouse Model 91%
Similar papers in this journal
- Explainable machine learning identifies features and thresholds predictive of immunotherapy response 92%
- Pan-cancer analyses of the associations between 109 pre-existing conditions and cancer treatment patterns across 19 adult cancers 92%
- Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy 91%
Similar papers in this journal
- CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade 93%
- Establishment and validation of pre-therapy cervical vertebrae muscle quantification as a prognostic marker of sarcopenia in head and neck patients receiving definitive cancer surgery 93%
- Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.